Prudential PLC lessened its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,772 shares of the company’s stock after selling 153 shares during the period. Prudential PLC’s holdings in Ryan Specialty were worth $1,269,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of RYAN. Sanctuary Advisors LLC grew its position in shares of Ryan Specialty by 1.2% in the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue increased its position in shares of Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after purchasing an additional 190 shares in the last quarter. CIBC Asset Management Inc raised its stake in Ryan Specialty by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after purchasing an additional 196 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in Ryan Specialty by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock valued at $755,000 after purchasing an additional 295 shares in the last quarter. Finally, UMB Bank n.a. boosted its stake in Ryan Specialty by 5.7% during the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company’s stock worth $354,000 after purchasing an additional 298 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.
Insider Buying and Selling at Ryan Specialty
In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of the business’s stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the transaction, the director now directly owns 45,409 shares of the company’s stock, valued at approximately $2,954,309.54. The trade was a 39.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,360 shares of company stock valued at $16,006,428 in the last 90 days. Company insiders own 11.10% of the company’s stock.
Ryan Specialty Stock Down 2.9 %
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.
Ryan Specialty Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.70%. Ryan Specialty’s dividend payout ratio is 69.57%.
Wall Street Analyst Weigh In
RYAN has been the subject of several research reports. Royal Bank of Canada dropped their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. UBS Group lifted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Keefe, Bruyette & Woods dropped their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a report on Friday, February 21st. Finally, Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $75.27.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Options Activity Points to More Volatility for Palantir Stock
- How to Start Investing in Real Estate
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.